Bio-Rad Laboratories Reports Shareholder Vote Matters

Ticker: BIO-B · Form: 8-K · Filed: Apr 25, 2025 · CIK: 12208

Bio-Rad Laboratories, Inc. 8-K Filing Summary
FieldDetail
CompanyBio-Rad Laboratories, Inc. (BIO-B)
Form Type8-K
Filed DateApr 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: BIO

TL;DR

BIO-RAD shareholders voted on key company matters as of April 22nd.

AI Summary

Bio-Rad Laboratories, Inc. filed an 8-K on April 25, 2025, reporting on matters submitted to a vote of security holders as of April 22, 2025. The filing details the company's corporate actions and governance related to shareholder decisions.

Why It Matters

This filing informs investors about key decisions made by Bio-Rad Laboratories' shareholders, impacting corporate governance and potentially future business strategies.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of shareholder vote matters and does not indicate any immediate financial or operational risks.

Key Players & Entities

  • BIO-RAD LABORATORIES, INC. (company) — Registrant
  • April 22, 2025 (date) — Date of earliest event reported
  • April 25, 2025 (date) — Date of report
  • 1000 Alfred Nobel Dr. Hercules , California 94547 (address) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on matters submitted to a vote of Bio-Rad Laboratories, Inc.'s security holders.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is April 22, 2025.

When was this 8-K report filed with the SEC?

This 8-K report was filed as of April 25, 2025.

What is Bio-Rad Laboratories, Inc.'s principal executive office address?

Bio-Rad Laboratories, Inc.'s principal executive office is located at 1000 Alfred Nobel Dr. Hercules, California 94547.

What is the Commission File Number for Bio-Rad Laboratories, Inc.?

The Commission File Number for Bio-Rad Laboratories, Inc. is 1-07928.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding BIO-RAD LABORATORIES, INC. (BIO-B).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.